Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Selpercatinib 160, Tumor Biomarker Defined

Protocol-ID: 1732 V1.0 (Mini), SELP160, Tumor Biomarker Defined

Indication(s)

  • Lung Carcinoma, Non-Small Cell (RET fusion positive); ICD-10 C34.-
  • Thyroid Cancer (RET fusion positive); ICD-10 C73
  • Tumor Biomarker Defined
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 21.02.2021